Hua et al [17] reported that a 44-year-old man with CML developed metabolic acidosis within 10 hours of nilotinib administration, which rapidly progressed to multiorgan and hepatic failure (bilirubin, 4.4 mg/dL; ALT, 1031 U/L). The gene discussed is GPT; the disease is Hepatic failure.